SpaceX begins trading on Nasdaq today under the ticker SPCX, pricing 555.6 million shares at $135 for a roughly $1.77 trillion valuation and a $75 billion raise, the largest IPO in United States history. The book, led by Goldman Sachs, came in four times oversubscribed. Retail investors received up to 30% of the offering, far above normal IPO allocations, and South Korean investors alone generated about $1.5 billion in dollar purchases linked to the deal. But for crypto, today is not just listing day. It is judgment day for an experiment that has been running since mid-May: can crypto markets price a company before Wall Street does?
Hyperliquid’s SPCX-USDC perpetual, launched May 17 via Trade.xyz at a $150 reference price, spiked to $216 and settled near $203 in the days before listing, implying a valuation as high as $2 trillion, roughly 70% above the $135 offer price, with funding rates running steeply positive since launch. Bybit’s tokenized SPCX, the real-equity version backed 1:1 via xStocks that we covered at launch, begins spot trading today as well. Arbitrageurs are positioned to short the perps and buy real shares the moment Nasdaq opens. If the synthetic price converges with the listed price within the first six trading hours, crypto’s on-chain pre-IPO price discovery is validated. If it does not, the gap becomes a cautionary tale about synthetic products with no redemption mechanism.
The Convergence Trade Explained
The mechanics are simple and the stakes are not. Synthetic SPCX products on Hyperliquid, Binance, OKX, Bitget, and BingX have been trading on belief alone: no underlying shares, no redemption, just funding rates and conviction. The Bybit and Kraken xStocks products are different, backed by real equity at the IPO price. When SPCX opens on Nasdaq today, every one of those venues gets marked against an actual market price for the first time. The CoinDesk read on the eve of listing was already cautious: the SPCX perpetual still trades above the $135 offer but has fallen sharply from its May highs as traders mark down the first-day premium.
Three outcomes are possible. A strong Nasdaq open near or above the perp price validates the crypto markets as a genuine price discovery venue and turbocharges the next wave of pre-IPO listings, with OpenAI and Anthropic IPO filings reportedly in drafting. A weak open well below the perp price hands losses to everyone who bought synthetic exposure at $200-plus, and gives regulators an exhibit: synthetic pre-IPO products from offshore exchanges have no precedent in US securities law, and a visible retail wipeout invites scrutiny. The third outcome, fast convergence with modest pain, is the one most arbitrage desks are betting on.
Where Everyone Priced SpaceX Before Nasdaq Opened
Pre-listing prices vs the $135 offer | June 11, 2026 | @cryptonewsbytes
Sources: TheStreet, Hyperliquid, BeInCrypto, Reuters | @cryptonewsbytes. Not financial advice.
What to Watch in the First Six Hours
The first checkpoint is the opening print itself: a pop above $160 keeps the perp premium partially honest, while an open near $140 makes the synthetic markets look 40% wrong. The second is funding rates on Hyperliquid, which flip negative the moment longs start unwinding into the real market. The third is the Bybit SPCX token’s spot debut, the first time tokenized real equity from an IPO trades 24/7 alongside its Nasdaq twin, creating a weekend price for SpaceX that the NYSE cannot offer. However today resolves, that last piece is permanent infrastructure. The IPO ends today. The 24/7 market for SpaceX equity is just beginning.
Frequently Asked Questions
Is the Hyperliquid SPCX perp backed by real SpaceX shares?
No. The SPCX-USDC contract on Hyperliquid is a perpetual future, a derivative settled in USDC with no underlying shares and no redemption mechanism. It tracks trader consensus, not custody. The Bybit and Kraken products via xStocks are different: tokenized representations backed 1:1 by real equity held in regulated broker-dealer custody, subscribed at the actual $135 IPO price.
What happens to the perp products after SPCX lists?
They continue trading, but the reference shifts from speculation to the live Nasdaq price. Arbitrage between the perp and the listed stock should force convergence, with funding rates penalizing whichever side is wrong. The bigger question is regulatory: synthetic pre-IPO products from offshore exchanges have no precedent in US securities law, and a high-profile divergence today could accelerate scrutiny and potential delistings on smaller venues.
Further Reading
Our launch coverage of the real-equity product that starts spot trading today, and how it differs from the synthetics.
The capital rotation side of today’s listing: where the $75 billion came from.
Today’s listing is the proof of concept for the real-vs-synthetic tokenized equity distinction Carlos Domingo drew at ETHConf.
This article is for informational purposes only and does not constitute financial advice. Sources: Reuters, TheStreet, BeInCrypto, CoinDesk, crypto.news, BTCC, Hyperliquid data. Published June 12, 2026.
